MUTATIONAL ANALYSIS OF TET2 GENE IN BCR-ABL1 NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS

被引：0
|
作者：
Euba, B. [1 ]
Aranaz, P. [1 ]
Garcia-Barchino, M. J. [1 ]
Hurtado, C. [1 ]
Calasanz, M. J. [1 ]
Novo, J. [1 ]
Vizmanos, J. L. [1 ]
Garcia-Delgado, M. [1 ]
机构：
[1] Univ Navarra, E-31080 Pamplona, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1503
引用
收藏
页码：597 / 598
页数：2
相关论文
共 50 条
  • [1] MUTATIONAL ANALYSIS OF THE EGF RECEPTOR GENE IN BCR-ABL1 NEGATIVE AND JAK2V617F NEGATIVE CHRONIC MYELOPROLIFERATIVE NEOPLASMS
    Aranaz, P.
    Hurtado, C.
    Ormazabal, C.
    Erquiaga, I.
    Calasanz, M. J.
    Garcia-Delgado, M.
    Novo, F. J.
    Vizmanos, J. L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 600 - 600
  • [2] Risk-adapted treatment of chronic BCR-ABL1 negative myeloproliferative neoplasms
    Heidel, Florian H.
    Doehner, Konstanze
    ONKOLOGE, 2019, 25 (11): : 985 - 993
  • [3] Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India
    Rabade, Nikhil
    Subramanian, P. G.
    Kodgule, Rohan
    Raval, Goutham
    Joshi, Swapnali
    Chaudhary, Shruti
    Mascarenhas, Russel
    Tembhare, Prashant
    Gujral, Sumeet
    Patkar, Nikhil
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (02) : 209 - 213
  • [4] Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnosticprinciples and upcoming updates
    Geyer, J. T.
    Orazi, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 12 - 19
  • [5] The Prevalence of TET2 Gene Mutations in Patients with BCR-ABL-Negative Myeloproliferative Neoplasms (MPN): A Systematic Review and Meta-Analysis
    Chia, Yuh Cai
    Islam, Md Asiful
    Hider, Phil
    Woon, Peng Yeong
    Johan, Muhammad Farid
    Hassan, Rosline
    Ramli, Marini
    CANCERS, 2021, 13 (12)
  • [6] Immunophenotypic Aberrancy on Basophils, a Biomarker for BCR-ABL1 Negative Myeloproliferative Neoplasms
    Chu, Andrew
    Kumar, Kirthi
    Monaghan, Sara A.
    Fuda, Franklin
    Chen, Weina
    LABORATORY INVESTIGATION, 2016, 96 : 340A - 340A
  • [7] Oxidant/Antioxidant Status in Patients with BCR-ABL1 Negative Myeloproliferative Neoplasms
    Benguella-Benmansour, Meriem
    Boucherit, Kebir
    Mesli, Naima
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2025, 41 (01) : 23 - 30
  • [8] Significance of Co-mutations in BCR-ABL1 Negative Myeloproliferative Neoplasms
    Zhou, Yi
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1054 - 1054
  • [9] Significance of Co-mutations in BCR-ABL1 Negative Myeloproliferative Neoplasms
    Zhou, Yi
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1054 - 1054
  • [10] Immunophenotypic Aberrancy on Basophils, a Biomarker for BCR-ABL1 Negative Myeloproliferative Neoplasms
    Chu, Andrew
    Kumar, Kirthi
    Monaghan, Sara A.
    Fuda, Franklin
    Chen, Weina
    MODERN PATHOLOGY, 2016, 29 : 340A - 340A
12345